PharmaForce 2016 (past event)
September 12 - 14, 2016
1.888.482.6012
Tamara Gaffney
Principal Analyst and Director
Adobe Systems, Inc.
Check out the incredible speaker line-up to see who will be joining Tamara.
Download The Latest AgendaSelecting the Channel Best Suited to Customer Engagement
Wednesday, January 4th, 2017
12:15 Interactive Roundtable Discussions
#1 Evolution of the U.S. Pharma Commercial Model in the New Healthcare Environment
Paul Darling, Principal, ZS Associates
#2 Mapping the Customer Journey to Create Positive Experiences that Engage Customers
Sandra Velez, Content Marketing Lead, Merck
#3 IMS Health Topic TBD
Justin Hawver, Sr Managed Services Consultant, IMS Health
Mark Klapper, Engagement Manager, IMS Health
#4 Getting the Most Out of Content and Inbound Marketing
Kevin Watson, Multichannel Marketing Engagement Lead, UCB
#5 Critical Decisions and Activities to Build a Commercial Infrastructure: Small Biopharma Perspective
Katie MacFarlane, Chief Commercial Officer, Agile Therapeutics
#6 Unlocking the Power of Clinical Diagnostics
Jason Bhan, Co-Founder, & Chief Medical Officer, Medivo
#7 Adobe Digital Index: state of digital healthcare
Tamara Gaffney, Adobe
#8 Specialty Care Data – Analytics
Ed Stelmack, AstraZeneca
Paul Darling, Principal, ZS Associates
#2 Mapping the Customer Journey to Create Positive Experiences that Engage Customers
Sandra Velez, Content Marketing Lead, Merck
#3 IMS Health Topic TBD
Justin Hawver, Sr Managed Services Consultant, IMS Health
Mark Klapper, Engagement Manager, IMS Health
#4 Getting the Most Out of Content and Inbound Marketing
Kevin Watson, Multichannel Marketing Engagement Lead, UCB
#5 Critical Decisions and Activities to Build a Commercial Infrastructure: Small Biopharma Perspective
Katie MacFarlane, Chief Commercial Officer, Agile Therapeutics
#6 Unlocking the Power of Clinical Diagnostics
Jason Bhan, Co-Founder, & Chief Medical Officer, Medivo
#7 Adobe Digital Index: state of digital healthcare
Tamara Gaffney, Adobe
#8 Specialty Care Data – Analytics
Ed Stelmack, AstraZeneca